These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics]. Belaizi M; Yahia A; Mehssani J; Bouchikhi Idrissi ML; Bichra MZ Encephale; 2013 Jun; 39(3):224-31. PubMed ID: 23095594 [TBL] [Abstract][Full Text] [Related]
29. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia. Komatsu T; Nomura T; Takami H; Sakamoto S; Mizuno K; Sekii H; Hatta K; Sugita M Intern Med; 2016; 55(19):2893-2897. PubMed ID: 27725556 [TBL] [Abstract][Full Text] [Related]
30. Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics. Hatch CD; Lund BC; Perry PJ Pharmacotherapy; 2001 Aug; 21(8):1003-6. PubMed ID: 11718487 [TBL] [Abstract][Full Text] [Related]
31. Anticholinergic toxicity masquerading as neuroleptic malignant syndrome: a case report and review. Catterson ML; Martin RL Ann Clin Psychiatry; 1994 Dec; 6(4):267-9. PubMed ID: 7647837 [TBL] [Abstract][Full Text] [Related]
32. [Mitigated presentation of the neuroleptic malignant syndrome]. Grandiek M; Ramlal AD; Blom JD Tijdschr Psychiatr; 2014; 56(2):114-7. PubMed ID: 24535768 [TBL] [Abstract][Full Text] [Related]
33. Psoas Abscess as a Differential Diagnosis of Neuroleptic Malignant Syndrome in a Schizoaffective Disorder Patient With Catatonic Symptoms. Hernandez-Huerta D; Montes JM Prim Care Companion CNS Disord; 2018 Nov; 20(6):. PubMed ID: 30444963 [No Abstract] [Full Text] [Related]
34. Neuroleptic malignant syndrome: a subtype of lethal catatonia? Ahuja N; Nehru R Acta Psychiatr Scand; 1990 Nov; 82(5):398. PubMed ID: 1980785 [No Abstract] [Full Text] [Related]
35. [Catatonic syndrome and neuroleptic malignant syndrome]. Ruzikowska A Psychiatr Pol; 1999; 33(3):415-25. PubMed ID: 10786241 [TBL] [Abstract][Full Text] [Related]
36. Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis. Osman AA; Khurasani MH Br J Psychiatry; 1994 Oct; 165(4):548-50. PubMed ID: 7804674 [TBL] [Abstract][Full Text] [Related]
37. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report]. Erol A; Putgül G; Sert E; Mete L Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268 [TBL] [Abstract][Full Text] [Related]
38. Neuroleptic malignant syndrome and catatonia: one entity or two? Fink M Biol Psychiatry; 1996 Jan; 39(1):1-4. PubMed ID: 8719118 [No Abstract] [Full Text] [Related]
39. Lethal catatonia and neuroleptic malignant syndrome. Greedharry D; Bowen R Can J Psychiatry; 1993 Apr; 38(3):236-7. PubMed ID: 8098989 [No Abstract] [Full Text] [Related]
40. Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. Castillo E; Rubin RT; Holsboer-Trachsler E Am J Psychiatry; 1989 Mar; 146(3):324-8. PubMed ID: 2645794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]